Selective inhibition of cannabinoid CB1 receptor-evoked signalling by the interacting protein GAP43

被引:0
|
作者
Maroto, Irene B.
Moreno, Estefania [4 ,5 ]
Costas-Insua, Carlos [1 ,2 ,3 ]
Merino-Gracia, Javier [1 ]
Diez-Alarcia, Rebeca [6 ,7 ,8 ]
Alvaro-Blazquez, Alicia
Canales, Angeles [9 ]
Canela, Enric I. [4 ,5 ]
Casado, Vicent [4 ,5 ]
Uriguen, Leyre [6 ,7 ,8 ]
Rodriguez-Crespo, Ignacio [1 ,2 ,3 ]
Guzman, Manuel [1 ,2 ,3 ]
机构
[1] Univ Complutense Madrid, Inst Univ Invest Neuroquim IUIN, Dept Biochem & Mol Biol, Madrid 28040, Spain
[2] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid 28029, Spain
[3] Inst Ramon y Cajal Invest Sanitaria IRYCIS, Madrid 28034, Spain
[4] Univ Barcelona, Fac Biol, Dept Biochem & Mol Biomed, Barcelona 08028, Spain
[5] Univ Barcelona, Inst Biomed, Barcelona 08028, Spain
[6] Univ Basque Country, Dept Pharmacol, Euskal Herriko Unibertsitatea, Leioa 48940, Spain
[7] Ctr Invest Biomed Red Salud Mental CIBERSAM, Madrid 28029, Spain
[8] Biocruces Bizkaia Hlth Res Inst, Baracaldo 48903, Bizkaia, Spain
[9] Univ Complutense Madrid, Inst Univ Invest Neuroquim IUIN, Dept Organ Chem, Madrid 28040, Spain
关键词
Cell signalling; CannabinoidCB1; receptor; Growth-associated protein of 43 kDa; Rho-associated coiled-coil containing protein; kinase; GAP-43; NEUROMODULIN; NEURITE OUTGROWTH; GROWTH; ACTIVATION; BRAIN; PHOSPHORYLATION; INTERNALIZATION; CANCER; CELLS; LOGIC;
D O I
10.1016/j.neuropharm.2023.109712
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Cannabinoids exert pleiotropic effects on the brain by engaging the cannabinoid CB1 receptor (CB1R), a pre -synaptic metabotropic receptor that regulates key neuronal functions in a highly context-dependent manner. We have previously shown that CB1R interacts with growth-associated protein of 43 kDa (GAP43) and that this interaction inhibits CB1R function on hippocampal excitatory synaptic transmission, thereby impairing the therapeutic effect of cannabinoids on epileptic seizures in vivo. However, the underlying molecular features of this interaction remain unexplored. Here, we conducted mechanistic experiments on HEK293T cells co -expressing CB1R and GAP43 and show that GAP43 modulates CB1R signalling in a strikingly selective manner. Specifically, GAP43 did not affect the archetypical agonist-evoked (i) CB1R/Gi/o protein-coupled sig-nalling pathways, such as cAMP/PKA and ERK, or (ii) CB1R internalization and intracellular trafficking. In contrast, GAP43 blocked an alternative agonist-evoked CB1R-mediated activation of the cytoskeleton-associated ROCK signalling pathway, which relied on the GAP43-mediated impairment of CB1R/Gq/11 protein coupling. GAP43 also abrogated CB1R-mediated ROCK activation in mouse hippocampal neurons, and this process led in turn to a blockade of cannabinoid-evoked neurite collapse. An NMR-based characterization of the CB1R-GAP43 interaction supported that GAP43 binds directly and specifically through multiple amino acid stretches to the C -terminal domain of the receptor. Taken together, our findings unveil a CB1R-Gq/11-ROCK signalling axis that is selectively impaired by GAP43 and may ultimately control neurite outgrowth.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Cannabinoid CB1 receptor inhibition decreases vascular smooth muscle migration and proliferation
    Rajesh, Mohanraj
    Mukhopadhyay, Partha
    Hasko, Gyoergy
    Pacher, Pal
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 377 (04) : 1248 - 1252
  • [42] Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716
    Terranova, JP
    Storme, JJ
    Lafon, N
    Perio, A
    RinaldiCarmona, M
    LeFur, G
    Soubrie, P
    PSYCHOPHARMACOLOGY, 1996, 126 (02) : 165 - 172
  • [43] Cannabinoid CB1 and CB2 receptor ligand specificity and the development of CB2-selective Agonists
    Ashton, John C.
    Wright, Jason L.
    McPartland, John M.
    Tyndall, Joel D. A.
    CURRENT MEDICINAL CHEMISTRY, 2008, 15 (14) : 1428 - 1443
  • [44] The synthetic CB1 cannabinoid receptor selective agonists: Putative medical uses and their legalization
    Coronado-Alvarez, Astrid
    Romero-Cordero, Karen
    Macias-Triana, Lorena
    Tatum-Kuri, Agnes
    Vera-Barron, Alba
    Budde, Henning
    Machado, Sergio
    Yamamoto, Tetsuya
    Imperatori, Claudio
    Murillo-Rodriguez, Eric
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2021, 110
  • [45] Recent Development of CB2 Selective and Peripheral CB1/CB2 Cannabinoid Receptor Ligands
    Nevalainen, Tapio
    CURRENT MEDICINAL CHEMISTRY, 2014, 21 (02) : 187 - 203
  • [46] Cannabinoid CB1 receptor inhibition decreases vascular smooth muscle migration and proliferation
    Pacher, Pal
    Rajesh, Mohanraj
    Mukhopadhyay, Partha
    Hasko, Gyoergy
    FASEB JOURNAL, 2009, 23
  • [47] Mutations in the conserved 'DRY' motif of the CB1 cannabinoid receptor result in functionally selective receptor conformations
    Gyombolai, P.
    Toth, A. D.
    Turu, G.
    Hunyady, L.
    ACTA PHYSIOLOGICA, 2014, 211 : 38 - 38
  • [48] Investigating selectivity and bias for G protein subtypes and β-arrestins by synthetic cannabinoid receptor agonists at the cannabinoid CB1 receptor
    Ryalls, Beth
    Patel, Monica
    Sparkes, Eric
    Banister, Samuel D.
    Finlay, David B.
    Glass, Michelle
    BIOCHEMICAL PHARMACOLOGY, 2024, 222
  • [49] The human eye expresses high levels of CB1 cannabinoid receptor mRNA and protein
    Porcella, A
    Maxia, C
    Gessa, GL
    Pani, L
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2000, 12 (03) : 1123 - 1127
  • [50] The G protein-coupled cannabinoid-1 (CB1) receptor of mammalian brain: Inhibition by phthalate esters in vitro
    Bisset, Kathleen M.
    Dhopeshwarkar, Amey S.
    Liao, Chengyong
    Nicholson, Russell A.
    NEUROCHEMISTRY INTERNATIONAL, 2011, 59 (05) : 706 - 713